<description>&lt;p&gt;The FDA has approved a pill version of the GLP-1 weight loss drug Wegovy from Novo Nordisk. The Department of Health and Human Services could be setting a new vaccine schedule. And ACA subsidies are set to expire at the end of the year. We speak with NBC News Medical Contributor Dr. Natalie Azar about the new developments and why the rising cost of health care is creating anxiety among nearly half of U.S. adults. Plus: Ahead of the holidays, we have weather, travel and shopping updates for your last-minute trips&lt;/p&gt;&lt;br/&gt; &lt;p&gt;Hosted by Simplecast, an AdsWizz company. See &lt;a href="https://pcm.adswizz.com"&gt;pcm.adswizz.com&lt;/a&gt; for information about our collection and use of personal data for advertising.&lt;/p&gt;</description>

Here's the Scoop

[email protected] (Brian Cheung, Bill Karins, Natalie Azar, Yasmin Vossoughian, Shaquille Brewster)

New GLP-1 Pills, Vaccine Schedules and ACA Costs – Plus, Last Ditch Holiday Shopping

DEC 23, 202524 MIN
Here's the Scoop

New GLP-1 Pills, Vaccine Schedules and ACA Costs – Plus, Last Ditch Holiday Shopping

DEC 23, 202524 MIN

Description

The FDA has approved a pill version of the GLP-1 weight loss drug Wegovy from Novo Nordisk. The Department of Health and Human Services could be setting a new vaccine schedule. And ACA subsidies are set to expire at the end of the year. We speak with NBC News Medical Contributor Dr. Natalie Azar about the new developments and why the rising cost of health care is creating anxiety among nearly half of U.S. adults. Plus: Ahead of the holidays, we have weather, travel and shopping updates for your last-minute trips Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.